|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2007-3-29
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Atherosclerosis is often advanced before symptoms appear and it is not clear whether treatment is beneficial in middle-aged individuals with a low Framingham risk score (FRS) and mild to moderate subclinical atherosclerosis.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1538-3598
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
28
|
|
pubmed:volume |
297
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1344-53
|
|
pubmed:dateRevised |
2009-2-11
|
|
pubmed:meshHeading |
pubmed-meshheading:17384434-Aged,
pubmed-meshheading:17384434-Atherosclerosis,
pubmed-meshheading:17384434-Carotid Arteries,
pubmed-meshheading:17384434-Cholesterol, LDL,
pubmed-meshheading:17384434-Double-Blind Method,
pubmed-meshheading:17384434-Female,
pubmed-meshheading:17384434-Fluorobenzenes,
pubmed-meshheading:17384434-Humans,
pubmed-meshheading:17384434-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:17384434-Lipids,
pubmed-meshheading:17384434-Male,
pubmed-meshheading:17384434-Middle Aged,
pubmed-meshheading:17384434-Pyrimidines,
pubmed-meshheading:17384434-Risk Assessment,
pubmed-meshheading:17384434-Sulfonamides,
pubmed-meshheading:17384434-Tunica Intima
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
|
|
pubmed:affiliation |
Department of Medicine, Wake Forest University, Winston-Salem, NC 27157, USA. jrcrouse@wfubmc.edu
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
